PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Drug Doxoform 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Drug Doxazolidine 9 8 0.00 -0.33 0.89 0.58
Arthritis 128,324 Disease Target CD254 9 1 0.00 -0.94 0.11 0.58
Hemorrhage 100,979 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58
Rheumatoid Arthritis 78,952 Disease Target CD254 9 1 0.00 -0.94 0.11 0.59
Prostate Cancer 71,064 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.59
Glaucoma 41,465 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.60
Prostate Cancer 71,064 Disease Drug Doxoform 9 2 0.00 -0.88 0.22 0.61
Colon Cancer 30,064 Disease Drug Doxorubicin-Formaldehyde Conjugate 9 1 0.00 -0.94 0.11 0.61
Colon Cancer 30,064 Disease Drug Doxoform 9 1 0.00 -0.94 0.11 0.61
Glomerulonephritis 23,459 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.62
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
Cox-2 21,583 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
Sarcoidosis 19,176 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
Colon Cancer 30,064 Disease Drug Doxazolidine 9 2 0.00 -0.88 0.22 0.63
Skin Cancer 11,561 Disease Target CD254 9 1 0.00 -0.94 0.11 0.63
bFGF 9,327 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.64
Retinitis 9,116 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.64
Androgen Receptor 12,918 Target Drug Doxorubicin-Formaldehyde Conjugate 9 2 0.01 -0.88 0.22 0.65
CD68 6,424 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.65
CCL4 5,638 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.65
CD95 4,266 Target Target CD254 9 1 0.01 -0.94 0.11 0.66
CCL2 3,560 Target Target CXCL4/PF4 9 2 0.01 -0.88 0.22 0.68
Cathepsin G 1,613 Target Target CINC-2- alpha 9 1 0.01 -0.94 0.11 0.69
CD154 1,512 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
Endoglin 1,333 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
CCL19 658 Target Target CXCL4/PF4 9 1 0.01 -0.94 0.11 0.71
BAFF 1,240 Target Target CD254 9 2 0.02 -0.88 0.22 0.72
CXCL9 1,016 Target Target CXCL4/PF4 9 2 0.02 -0.88 0.22 0.72
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
CCL3 1,427 Target Target CXCL4/PF4 9 3 0.03 -0.82 0.33 0.72
CD137 474 Target Target CD254 9 1 0.02 -0.94 0.11 0.72
BLyS 457 Target Target CD254 9 1 0.02 -0.94 0.11 0.73
CCL8 197 Target Target CXCL4/PF4 9 1 0.02 -0.94 0.11 0.75
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
Doxoform 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
Aminocaproic Acid (Amicar)- FDA 5 Drug Drug Aprotinin (Trasylol)- FDA 9 2 0.30 -0.68 0.40 0.92
Amicar (Aminocaproic Acid)- FDA 5 Drug Drug Aprotinin (Trasylol)- FDA 9 2 0.30 -0.68 0.40 0.92
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxoform 9 4 0.44 -0.56 0.44 0.95
Infection 766,637 Disease Disease Lupus Erythematosus Discoid 10 1 0.00 -0.95 0.10 0.54
Infection 766,637 Disease Drug Amikacin (Amikin)- FDA 10 1 0.00 -0.95 0.10 0.54
Infection 766,637 Disease Drug Amikin (Amikacin)- FDA 10 1 0.00 -0.95 0.10 0.54
Carcinoma 433,099 Disease Drug Arimidex (Anastrozole)- FDA 10 1 0.00 -0.95 0.10 0.55
Carcinoma 433,099 Disease Drug Anastrozole (Arimidex)- FDA 10 1 0.00 -0.95 0.10 0.55
Cancer 1,053,491 Disease Drug Drometrizole 10 3 0.00 -0.84 0.30 0.56
Diabetes 332,602 Disease Target ADRBK1 10 1 0.00 -0.95 0.10 0.56